Yurts Technologies
548 Market St., PMB 95683, San Francisco, CA, 94104, United States
Overview
Yurts builds an AI integration platform designed to run in high-security and secret networks, positioning its chat assistant as an enterprise-ready interface for legacy systems. The product is deployed within Department of Defense environments and can be used for tasks from pulling data from old reports to brainstorming military technology use cases. Cofounded by Ben Van Roo in August 2022 alongside former Meta engineer Jason Schnitzer and research scientist Guruprasad Raghavan, the team has grown to about 50 employees, roughly a quarter of whom hold security clearances. Yurts currently holds contracts with the U.S. Army, U.S. Air Force, Department of Energy, and a $16 million contract with U.S. Special Operations Command. The company emphasizes secure deployment and integration of foundation models rather than building base models itself. Leadership frames the opportunity as rolling AI out to tens of thousands of users in secure enterprise environments. Yurts offers an enterprise-ready Generative AI platform that converges documents from SharePoint, Teams, Slack, Google Docs and other sources into a flexible, controlled repository. The platform helps enterprises find, connect, and communicate across systems, applications, and documents and accelerate workflows via application interfaces or within existing apps. It emphasizes integration with existing systems without long implementation timelines, high GPU costs, or requiring in-house ML/AI experts. Yurts leverages LLMs and GenAI applications to work with knowledge management and enterprise workflows at scale. The company plans to use the Series A funds to continue building its secure AI platform and to expand its technology team. Yurts was co-founded in 2022 and is based in San Francisco, CA.
- Total raised
- $56M
- Funding rounds
- 2
- Latest round
- Series B
- Latest activity
- Dec 2024
Industries
- Artificial Intelligence (AI)
- Information Technology
- Software
Recent funding
Series B
Dec 2024
$40M
Series A
Sep 2023
$16M